TOP STORIES

• BUSINESS Nomura Picked as Next Chief of Sumitomo Dainippon, Vows to Build Peripheral Healthcare Biz
  February 26, 2018

• REGULATORY Shionogi’s Single-Dose Flu Med Gets Accelerated OK
  February 26, 2018

• TRENDS Countering Abilify Cliff, Otsuka Sees New Drug Franchise Set Stage for Growth Path
  February 23, 2018

• ACADEMIA Major Drug Makers to Join in AMED Project to Develop “Organs on Chips” as New Tools for Drug Discovery
  February 22, 2018

• BUSINESS Aducanumab Trial Tweak “Common Decision” to Boost Statistical Confidence: Biogen CEO
  February 21, 2018

• BUSINESS Takeda’s Specialty Biz Unit Most Likely to Handle GI Meds, Entyvio Launch Apparently Eyed
  February 20, 2018

• REGULATORY Turning Point for Blood Products? Discussions on Basic Policy on Blood Law Moving Ahead
  February 20, 2018

• REGULATORY Chugai Hemophilia Drug, Novel Zoster Vaccine Set for Approval Review on March 2
  February 19, 2018

• REGULATORY 20 Gx Makers Flock to Aimix, Sawai Earns Approval for Tamiflu Copy for June Listing
  February 16, 2018

• BUSINESS Sumitomo Dainippon Sues 2 Gx Makers over Latuda, Delays New 5-Year-Plan Announcement
  February 15, 2018

• REGULATORY MHLW Looked at Balance and Made Major Revision Plans for Drug Pricing: Official
  February 14, 2018

• BUSINESS Pricing Revamp for Off-Patent Brands “Within Our Expectation”: LTL Pharma CEO
  February 13, 2018

• ORGANIZATION Private Univ. Group Encourages “Single-Product, Single-Price” Deals in Response to New Distribution GL, Tougher Medical Fee Cut Rules
  February 9, 2018

• TRENDS With 2 Players Closing in on Suglat, SGLT2 Inhibitors Entering Triangular Battle
  February 8, 2018

• REGULATORY Chuikyo Submits Recommendation for FY2018 Reimbursement Policy Reform, Drug Pricing Package Enshrined
  February 8, 2018

• BUSINESS EA Pharma Launches Rectabul, Boosts Efforts on Humira to Gird for IBD Showdown
  February 7, 2018

• BUSINESS Poxel Eyeing Japan as 1st Market for Its Lead Diabetes Candidate: CEO
  February 6, 2018

• BUSINESS PorMedTec to Support Development Using Disease Model Pigs, Clients Already Include One Major Drug Maker
  February 6, 2018

• REGULATORY Japan’s 1st Herceptin Biosimilar Clears MHLW Panel, Now in Line for March Approval for Gastric Cancer
  February 5, 2018

• INTERVIEW Interview: Pfizer Japan Looks to Offer High Quality Biosimilars with Go-It-Alone Strategy
  February 2, 2018

ページ

• « 先頭
• ‹ Prev
• …
• 144
• 145
• 146
• 147
• 148
• 149
• 150
• 151
• 152
• …
• Next ›
• 最終 »